Proliferation of myofibroblasts in the stroma of renal oncocytoma.
OBJECTIVE
Myofibroblasts are a vital component of stroma of many malignant neoplasms, but it is not yet established whether stromal myofibroblasts also exist in benign tumours such as oncocytoma of the kidney.


METHODS
Histomorphological and immunohistochemical analysis of 16 renal oncocytomas diagnosed at Chang Gung Memorial Hospital, Taiwan, has been performed.


RESULTS
Renal oncocytomas were composed of oncocytes, large cells with granular eosinophilic cytoplasm, arranged mostly in sheets, in tubulocystic or combined pattern. Few oncocytes appeared to be undergoing proliferation or apoptosis. MIB-1 and active caspase 3 indices were low, but higher in tumour than in surrounding non-tumour parenchyma (MIB-1: 0.93 +/- 0.09 versus 0.46 +/- 0.07, P < 0.001 and active caspase 3: 0.76 +/- 0.08 versus 0.41 +/- 0.09, P < 0.001). Wnt/beta-catenin signalling was not implicated in this neoplasm, as there was no loss of E-cadherin membranous localization or expression of intranuclear beta-catenin in the cells. Clumps of oncocytes were stained with periodic acid Schiff and had collagen I-, collagen III- and fibronectin-positive, but desmin- and human caldesmon-negative stromas. Importantly, alpha-smooth muscle actin (SMA)-immunostaining established the myofibroblastic nature of many of the stromal cells. Some of the myofibroblasts were also positive for MIB-1, indicating a proliferative role for them in the stroma.


CONCLUSIONS
Renal oncocytomas were composed of two independent compartments: benign oncocytes and pronounced fibrotic stroma, which consisted of proliferating myofibroblasts (SMA- and MIB-1-positive) which were associated with excessive deposition of extracellular matrix (periodic acid Schiff-component, collagen I-, collagen III- and fibronectin-positive, and desmin- and human caldesmon-negative).
Yen
T-H
TH
Departments of Nephrology, Chang Gung Memorial Hospital, Taipei, Taiwan. m19570@adm.cgmh.org.tw
Chen
Y
Y
Fu
J-F
JF
Weng
C-H
CH
Tian
Y-C
YC
Hung
C-C
CC
Lin
J-L
JL
Yang
C-W
CW
D018249:Adenoma, Oxyphilic / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D049109:Cell Proliferation; D005109:Extracellular Matrix / Q000378:metabolism / Q000473:pathology; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D005260:Female; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D032446:Myoblasts / Q000378:metabolism / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000473:pathology / Q000503:physiopathology; D017154:Stromal Cells / Q000378:metabolism / Q000473:pathology
D014408:Biomarkers, Tumor; D016326:Extracellular Matrix Proteins
Br J Cancer. 2003 Mar 10;88(5):775-81
12618889
Oncogene. 2000 Nov 30;19(51):5898-905
11127821
Cancer. 1976 Aug;38(2):906-14
975006
Am J Pathol. 1984 Jun;115(3):329-33
6329001
Virchows Arch. 2002 Mar;440(3):298-303
11889601
Lab Invest. 1990 Aug;63(2):144-61
2116562
Cell Prolif. 2008 Aug;41(4):592-606
18699966
Br J Cancer. 1994 Aug;70(2):244-7
7914422
Cardiovasc Res. 2006 Sep 1;71(4):661-71
16854401
Cell Prolif. 2007 Apr;40(2):143-56
17472723
Clin Cancer Res. 2002 Sep;8(9):2912-23
12231536
Virchows Arch. 2002 Dec;441(6):564-8
12461613
Nat Rev Cancer. 2001 Oct;1(1):46-54
11900251
Cancer Res. 2007 Mar 1;67(5):2062-71
17332335
Int J Biochem Cell Biol. 2007;39(12):2153-60
17825600
Hum Pathol. 2005 Jan;36(1):16-21
15712177
Prog Mol Subcell Biol. 2000;25:105-34
10986721
Cancer Res. 2004 Dec 1;64(23):8492-5
15574751
Int J Cancer. 1988 May 15;41(5):707-12
2835323
Circ Res. 2003 Oct 17;93(8):e76-86
14512446
Int J Cancer. 2008 Nov 15;123(10):2229-38
18777559
Hepatology. 1997 Dec;26(6):1458-66
9397985
N Engl J Med. 1986 Dec 25;315(26):1650-9
3537791
Nat Rev Cancer. 2006 May;6(5):392-401
16572188
Pathology. 2007 Jun;39(3):305-18
17558857
J Clin Invest. 1995 Feb;95(2):859-73
7532191
Cancer Res. 2001 Jan 15;61(2):550-5
11212248
J Urol. 1993 Aug;150(2 Pt 1):295-302
8326547
Gastroenterology. 2005 Jun;128(7):1984-95
15940631
J Biol Chem. 1999 Dec 17;274(51):36505-12
10593948
Cancer Metastasis Rev. 1998-1999;17(4):411-9
10453285
J Hepatol. 2006 Sep;45(3):429-38
16846660
J Clin Invest. 2003 Dec;112(12):1776-84
14679171
J Immunol. 2001 Jun 15;166(12):7556-62
11390511
Virchows Arch. 2002 Feb;440(2):128-133
11964041
Circulation. 2007 Oct 30;116(18):2053-61
17938286
Pathol Res Pract. 1996 Jul;192(7):712-7
8880872
Stem Cell Rev. 2006;2(3):203-12
17625256
J Clin Invest. 2002 Aug;110(3):341-50
12163453
Cell Prolif. 2008 Aug;41(4):575-91
18616694
J Surg Oncol. 1993 May;53(1):36-42
8479195
Hum Exp Toxicol. 1995 Dec;14(12):935-44
8962743
J Pathol. 2003 Jul;200(4):500-3
12845617
J Am Soc Nephrol. 2004 Jan;15(1):1-12
14694152